Study Group: IBD Gastroenterologists

Council Members in this Study Group: 301

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Mazen Jamal

Chief of Endoscopy
UNITED STATES DEPT OF VETERANS AFFAIRS - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Mazen Jamal, MD, MPH, is Chief of Gastrointestinal Endoscopy and Outpatient Services at the Long Beach VA Medical Center. Dr. Jamal is also Clinical Professor of Medicine at the University of California, Irvine and consults through his own company, MMJ...

4 news post(s)
1 event(s)
Miguel Rodriguez

Hepatologist and Gastroenterologist
Miami Gastroenterology Consultants PA
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Miguel Rodriguez, MD, is a Hepatologist, Gastroenterologist, and a Managing Partner of the Miami Gastroenterology Consultants PA, a single specialty group in Miami, Florida, since October 2000. He is former Assistant Professor of Medicine of the University...

Stefan Schreiber

Professor
CHRISTIAN ALBRECHTS UNIVERSITAT ZU KIEL
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Stefan Schreiber, MD, is Professor of Medicine and Gastroenterology at the Christian-Albrechts-University in Germany. Dr. Schreiber is responsible for designing, organizing, and conducting phase IB-III clinical trials of novel drugs for inflammatory bowel...

Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Academic Institution*
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Owner

Related Study Groups

Study Group Name No. Members
Gastroenterologists who Treat GERD 419
Xifaxan Prescribers for Hepatic Encephalopathy (US) 41
Physicians who Treat Graft-versus-Host disease 65
Pancreatic Cancer Oncologists in the U.S. 143
GI Cancer Oncologists (US) 86
Pediatric Allergy Physicians 183
Neurologists (EU) 581
Physicians Who Treat Acute Pancreatitis (US) 32

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in IBD Gastroenterologists Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

Teleconference: FDA Advisory Committee Announcement Salix Pharmaceuticals' Xifaxan (11:00 AM EST)

2/24/2010